A fusion peptide directs enhanced systemic dystrophin exon skipping and functional restoration in dystrophin-deficient mdx mice.
Duchenne muscular dystrophy (DMD) is caused by mutations in the DMD gene that abolish the synthesis of dystrophin protein. Antisense oligonucleotides (AOs) targeted to trigger excision of an exon bearing a mutant premature stop codon in the DMD transcript have been shown to skip the mutated exon and...
Main Authors: | Yin, H, Moulton, H, Betts, C, Seow, Y, Boutilier, J, Iverson, P, Wood, M |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
2009
|
Registos relacionados
-
Functional rescue of dystrophin-deficient mdx mice by a chimeric peptide-PMO
Por: Yin, H, et al.
Publicado em: (2010) -
Hexose enhances oligonucleotide delivery and exon skipping in dystrophin-deficient mdx mice
Por: Gang Han, et al.
Publicado em: (2016-03-01) -
Good news for the mdx mouse community: Improved dystrophin restoration after skipping mouse dystrophin exon 23
Por: Annemieke Aartsma-Rus
Publicado em: (2022-12-01) -
Context dependent effects of chimeric peptide morpholino conjugates contribute to dystrophin exon-skipping efficiency
Por: Yin, HF, et al.
Publicado em: (2016) -
Cmah-dystrophin deficient mdx mice display an accelerated cardiac phenotype that is improved following peptide-PMO exon skipping treatment
Por: Betts, C, et al.
Publicado em: (2018)